Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 6397

1.

Move along, nothing to see here: Btk inhibitors stop platelets sticking to plaques.

Bye AP, Gibbins JM.

J Thromb Haemost. 2018 Jul 20. doi: 10.1111/jth.14201. [Epub ahead of print] No abstract available.

PMID:
30030898
2.

Tissue Factor at the crossroad of coagulation and cell signaling.

Zelaya H, Rothmeier A, Ruf W.

J Thromb Haemost. 2018 Jul 21. doi: 10.1111/jth.14246. [Epub ahead of print] Review.

PMID:
30030891
3.

Summertime.

Rosendaal FR, Reitsma PH.

J Thromb Haemost. 2018 Jul 20. doi: 10.1111/jth.14228. [Epub ahead of print] No abstract available.

PMID:
30027662
4.

Role of direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism: guidance from the SSC of the ISTH.

Khorana AA, Noble S, Lee AYY, Soff G, Meyer G, O'Connell C, Carrier M.

J Thromb Haemost. 2018 Jun 29. doi: 10.1111/jth.14219. [Epub ahead of print] No abstract available.

PMID:
30027649
5.

What The Neighbor Says.

[No authors listed]

J Thromb Haemost. 2018 Jul 19. doi: 10.1111/jth.14229. [Epub ahead of print] No abstract available.

PMID:
30022599
6.

Heparin-protamine balance after neonatal cardiopulmonary bypass surgery.

Peterson JA, Maroney SA, Zwifelhofer W, Wood JP, Yan K, Bercovitz RS, Woods RK, Mast AE.

J Thromb Haemost. 2018 Jul 17. doi: 10.1111/jth.14245. [Epub ahead of print]

PMID:
30016577
7.

Small molecule targeting the Rac1-NOX2 interaction prevents collagen-related peptide and thrombin induced reactive oxygen species generation and platelet activation.

Akbar H, Duan X, Piatt R, Saleem S, Davis AK, Tandon NN, Bergmeier W, Zheng Y.

J Thromb Haemost. 2018 Jul 14. doi: 10.1111/jth.14240. [Epub ahead of print]

PMID:
30007118
8.

Longitudinal increase in blood biomarkers of inflammation or cardiovascular disease and the incidence of venous thromboembolism.

Folsom AR, Lutsey PL, Heckbert SR, Poudel K, Basu S, Hoogeveen RC, Cushman M, Ballantyne CM.

J Thromb Haemost. 2018 Jul 14. doi: 10.1111/jth.14241. [Epub ahead of print]

PMID:
30007116
9.

Laboratory criteria for antiphospholipid syndrome: communication from the SSC of the ISTH: comment.

Kackner K, Müller-Calleja N.

J Thromb Haemost. 2018 Jul 14. doi: 10.1111/jth.14237. [Epub ahead of print]

PMID:
30007114
10.

Laboratory criteria for antiphospholipid syndrome: reply.

Devreese KMJ, Ortel TL, Pengo V, de Laat B.

J Thromb Haemost. 2018 Jul 14. doi: 10.1111/jth.14238. [Epub ahead of print]

PMID:
30007111
11.

Factor XI promotes hemostasis in factor IX deficient mice.

Mohammed BM, Cheng Q, Matafonov A, Monroe DM, Meijers JCM, Gailani D.

J Thromb Haemost. 2018 Jul 14. doi: 10.1111/jth.14243. [Epub ahead of print]

PMID:
30007049
12.

Assessment of Whole Blood Coagulation with a Microfluidic Dielectric Sensor.

Maji D, De La Fuente M, Kucukal E, Sekhon UDS, Schmaier AH, Sen Gupta A, Gurkan UA, Nieman MT, Stavrou EX, Mohseni P, Suster MA.

J Thromb Haemost. 2018 Jul 14. doi: 10.1111/jth.14244. [Epub ahead of print]

PMID:
30007048
13.

Nano-evidence for Joint Microbleeds in Hemophilia Patients.

Puetz J.

J Thromb Haemost. 2018 Jul 14. doi: 10.1111/jth.14242. [Epub ahead of print]

PMID:
30007042
14.

The chaperone-like sodium phenylbutyrate improves factor IX intracellular trafficking and activity impaired by the frequent p.R294Q mutation.

Pignani S, Todaro A, Ferrarese M, Marchi S, Lombardi S, Balestra D, Pinton P, Bernardi F, Pinotti M, Branchini A.

J Thromb Haemost. 2018 Jul 11. doi: 10.1111/jth.14236. [Epub ahead of print]

PMID:
29993188
15.

Mechanisms and mitigating factors for venous thromboembolism in chronic kidney disease: the REGARDS Study.

Cheung KL, Zakai NA, Callas PW, Howard G, Mahmoodi BK, Peralta CA, Judd SE, Kurella Tamura M, Cushman M.

J Thromb Haemost. 2018 Jul 8. doi: 10.1111/jth.14235. [Epub ahead of print]

PMID:
29984467
16.

PDK1 governs thromboxane generation and thrombosis in platelets by regulating activation of Raf1 in the MAPK pathway: comment.

Patel P, Golla K, Naik UP.

J Thromb Haemost. 2018 Jul 7. doi: 10.1111/jth.14232. [Epub ahead of print]

PMID:
29983001
17.

Targeting platelet EPCR for better therapeutic factor VIIa activity.

Gu SX, Lentz SR.

J Thromb Haemost. 2018 Jul 7. doi: 10.1111/jth.14231. [Epub ahead of print]

PMID:
29982998
18.

Anti-C1 Domain Antibodies That Accelerate Factor VIII Clearance Contribute to Antibody Pathogenicity in a Murine Hemophilia A Model.

Batsuli G, Ito J, Mercer R, Baldwin WH, Cox C, Parker ET, Healey JF, Lollar P, Meeks SL.

J Thromb Haemost. 2018 Jul 7. doi: 10.1111/jth.14233. [Epub ahead of print]

PMID:
29981270
19.

Flavin monooxygenase 3, the host hepatic enzyme in the metaorganismal trimethylamine N-oxide-generating pathway, modulates platelet responsiveness and thrombosis risk.

Zhu W, Buffa JA, Wang Z, Warrier M, Schugar R, Shih DM, Gupta N, Gregory JC, Org E, Fu X, Li L, DiDonato JA, Lusis AJ, Brown JM, Hazen SL.

J Thromb Haemost. 2018 Jul 7. doi: 10.1111/jth.14234. [Epub ahead of print]

PMID:
29981269
20.

PDK1 governs thromboxane generation and thrombosis in platelets by regulating activation of Raf1 in the MAPK pathway: Reply.

Manne BK, Rondina MT.

J Thromb Haemost. 2018 Jul 7. doi: 10.1111/jth.14230. [Epub ahead of print]

PMID:
29981265

Supplemental Content

Loading ...
Support Center